204840 — GL Pharm Tech Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual income statement for GL Pharm Tech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	12,426	16,729	26,033	26,048	35,268
Cost of Revenue
Gross Profit	3,769	4,877	8,709	10,307	14,329
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	15,398	18,972	28,749	27,816	34,999
Operating Profit	-2,973	-2,244	-2,716	-1,768	268
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-3,842	-832	-3,944	-2,332	76
Provision for Income Taxes
Net Income After Taxes	-3,734	-790	-3,749	-2,337	12.5
Minority Interest
Net Income Before Extraordinary Items
Net Income	-3,727	-790	-3,749	-2,337	12.5
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-3,727	-790	-3,749	-2,337	12.5
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-69.4	-41.3	-65.6	-31.6	0.086
Dividends per Share